Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman

Summary

This is a double blind, randomised, placebo-controlled trial to evaluate orally-dosed IHAT (iron hydroxide adipate tartrate) at 2 different doses compared to placebo for increasing serum ferritin levels in iron-deficient but otherwise healthy premenopausal women over 12 weeks.

Timeline

Start

2024-03-06

Primary completion

2025-02-03

Completion

2025-02-03

Drugs

Indications